Trilaciclib Combined With Chemotherapy for Perioperative Treatment of Osteosarcoma

Summary

This study is a prospective, single arm phase II study aimed at evaluating the efficacy and safety of trilaciclib before perioperative chemotherapy in patients with osteosarcoma.

Timeline

Start

2024-02-01

Primary completion

2025-02-01

Completion

2025-08-01

Drugs

Indications